Current Neuro-Oncology
Volume
25 Number 19
15 October 2023
Home > Publications > Current Neuro-Oncology > Volume 25, Year 2023 > Number 19, 15 October
*
Gu P, Ding Y, Zheng G, Xu P, Xia
X.
Extracranial
metastasis of glioblastoma: A case report and literature
review.
Int J
Surg Case Rep. 2023 Oct 1;111:108895∟.
doi: 10.1016/j.ijscr.2023.108895∟.
PMID: 37812956∟.
Case report, Review. ˍ
Moritsubo M, Furuta T, Negoto T,
Nakamura H, Uchiyama Y, Morioka M, Oshima K, Sugita Y.
A
case of a pilocytic astrocytoma with histological features of
anaplasia and unprecedent genetic alterations.
Neuropathology.
2023 Oct 1∟.
doi: 10.1111/neup.12946∟.
PMID: 37779355∟.
Case report˰ ˍ
Brady K, Cohen AL.
Differences
in Symptom Burden in Primary Brain Tumor Patients Based on Sex,
Race, and Ethnicity: a Single-Center Retrospective Study.
J
Racial Ethn Health Disparities. 2023 Oct 2∟.
doi: 10.1007/s40615-023-01761-9∟.
PMID: 37783921∟.
Observational study. ˍ
Que T, Huang G, Tan JE, Zhang P, Li
Z, Yi G, Zheng H, Yuan X, Xiao X, Liu J, Xu H, Zhang XA, Qi
S.
Supramaximal
resection based on en-bloc technique reduces tumor burden and
prolongs survival in primary supratentorial lobar glioblastoma.
J
Neurooncol. 2023 Oct 2∟.
doi: 10.1007/s11060-023-04399-z∟.
PMID: 37783878∟.
Observational study˰
ˍ
Blakstad H, Mendoza Mireles EE, Heggebø LC, Magelssen H,
Sprauten M, Johannesen TB, Vik-Mo EO, Leske H, Niehusmann P,
Skogen K, Helseth E, Emblem KE, Brandal P.
Incidence
and outcome of pseudoprogression after radiation therapy in
glioblastoma patients: A cohort study.
Neurooncol
Pract. 2023 Oct 3;11(1):36-45. doi:
10.1093/nop/npad063. PMID:
38222046. Observational study. ˍ
Weller J, Zeyen T, Schäfer N,
Schaub C, Potthoff AL, Steinbach JP, Hau P, Seidel C, Goldbrunner
R, Tabatabai G, Vatter H, Tzaridis T, Schneider M, Herrlinger
U.
The
proneural subtype is not associated with survival benefit from
bevacizumab in newly diagnosed glioblastoma: a secondary analysis
of the GLARIUS trial.
J
Neurooncol. 2023 Oct 3∟.
doi: 10.1007/s11060-023-04470-9∟.
PMID: 37787906∟.
Interventional study. ˍ
*
Dadey DYA, Medress ZA, Sharma M,
Ugiliweneza B, Wang D, Rodrigues A, Parker J, Burton E, Williams
B, Han SS, Boakye M, Skirboll S.
Risk
of developing glioblastoma following non-CNS primary cancer: a
SEER analysis between 2000 and 2018.
J
Neurooncol. 2023 Oct 4∟.
doi: 10.1007/s11060-023-04460-x∟.
PMID: 37792220∟.
Observational study˰ ˍ
Engelhardt M, Grittner U, Krieg S,
Picht T.
Preconditioning
of the motor network with repetitive navigated transcranial
magnetic stimulation (rnTMS) to improve oncological and functional
outcome in brain tumor surgery: a study protocol for a randomized,
sham-controlled, triple-blind clinical trial.
Trials.
2023 Oct 4;24(1):638∟.
doi: 10.1186/s13063-023-07640-2∟.
PMID: 37794435∟.
Interventional study protocol. ˍ
*
Ostrom QT, Price M, Neff C, Cioffi
G, Waite KA, Kruchko C, Barnholtz-Sloan JS.
CBTRUS
Statistical Report: Primary Brain and Other Central Nervous System
Tumors Diagnosed in the United States in 2016-2020.
Neuro
Oncol. 2023 Oct 4;25(Supplement_4):iv1-iv99∟.
doi: 10.1093/neuonc/noad149∟.
PMID: 37793125∟.
Observational study. ˍ
*
Sirirungreung A, Lee PC, Hu YH,
Liew Z, Ritz B, Heck JE.
Maternal
medically diagnosed infection and antibiotic prescription during
pregnancy and risk of childhood cancer: A population-based cohort
study in Taiwan, 2004 to 2015.
Int
J Cancer. 2023 Oct 4∟.
doi: 10.1002/ijc.34744∟.
PMID: 37792464∟.
Observational study˰ ˍ
Fan X, You H, Liu J, Tao X, Wang M,
Li K, Yang J, Xie J, Qiao H.
The
Utility of Motor Evoked Potential Monitoring for Predicting
Postoperative Motor Deficit in Patients With Insular Gliomas.
J
Clin Neurophysiol. 2023 Oct 5∟.
doi: 10.1097/WNP.0000000000001026∟.
PMID: 37797240∟.
Observational study˰ ˍ
Loughan AR, Lanoye A, Willis KD,
Fox A, Ravyts SG, Zukas A, Kim Y.
Telehealth
group Cognitive Behavioral Therapy for Insomnia (CBT-I) in primary
brain tumor: Primary outcomes from a single-arm Phase 2
feasibility and proof-of-concept trial.
Neuro
Oncol. 2023 Oct 5:noad193∟.
doi: 10.1093/neuonc/noad193∟.
PMID: 37796017∟.
Proof-of-concept trial˰ ˍ
Nair JN, Naidu B, Balasubramanian
A, Krishnamurthy G.
Polymorphous
low-grade neuroepithelial tumour of young (PLNTY): the new kid on
the block.
Childs
Nerv Syst. 2023 Oct 5∟.
doi: 10.1007/s00381-023-06162-1∟.
PMID: 37796295∟.
Case report˰ ˍ
Wang Y, Wu X, Luo B, Ren
H.
Clinicopathologic
features and prognosis analysis of infratentorial diffuse
gliomas.
Asian J
Surg. 2023 Oct 5:S1015-9584(23)01535-X∟.
doi: 10.1016/j.asjsur.2023.09.119∟.
PMID: 37805332∟.
Letter, Observational study. ˍ
*
Kim J, Kim Y, La J, Park WH, Kim
HJ, Park SH, Ku KB, Kang BH, Lim J, Kwon MS, Lee
HK.
Supplementation
with a high-glucose drink stimulates anti-tumor immune responses
to glioblastoma via gut microbiota modulation.
Cell
Rep. 2023 Oct 6;42(10):113220∟. doi:
10.1016/j.celrep.2023.113220∟.
PMID: 37804509∟.
Laboratory investigation. ˍ
Kinslow C, Siegelin MD, Iwamoto FM,
Gallitto M, Neugut AI, Yu JB, Cheng SK, Wang TJC.
MGMT
promoter methylation in 1p19q-intact gliomas.
Res
Sq [Preprint]. 2023 Oct 6:rs.3.rs-3393238∟.
doi: 10.21203/rs.3.rs-3393238/v1∟.
PMID: 37886555∟.
Observational study. ˍ
Saeed N, Ridzuan M, Alasmawi H,
Sobirov I, Yaqub M.
MGMT
promoter methylation status prediction using MRI scans? An
extensive experimental evaluation of deep learning models.
Med
Image Anal. 2023 Oct 6;90:102989∟.
doi: 10.1016/j.media.2023.102989∟.
PMID: 37827111∟.
Observational study. ˍ
Ernster AE, Body A, Deleyrolle P,
St Clair J, Sampson D, Bacharz K, Yan SC, Melnick K, Allen A,
Rahman M, Tran DD, Mitchell DA, Pereira DB, Ghiaseddin AP.
Patterns
and predictors of anxiety and depression symptom trajectories in
patients diagnosed with primary brain tumors.
J
Neurooncol. 2023 Oct 7∟.
doi: 10.1007/s11060-023-04469-2∟.
PMID: 37804375∟.
Observational study˰ ˍ
Ciobanu-Caraus O, Czech T, Peyrl A,
Haberler C, Kasprian G, Furtner J, Kool M, Sill M, Frischer JM,
Cho A, Slavc I, Rössler K, Gojo J, Dorfer C.
The
Site of Origin of Medulloblastoma: Surgical Observations
Correlated to Molecular Groups.
Cancers
(Basel). 2023 Oct 7;15(19):4877∟.
doi: 10.3390/cancers15194877∟.
PMID: 37835571∟.
Observational study. ˍ
Kotch C, Si SJ, Desai K, Caminada
P, Lo Russo FM, Li Y, Liu GT, Avery RA, Fisher MJ.
The
impact of changes in gadolinium-enhancement on disease progression
in children with neurofibromatosis type 1-associated optic pathway
glioma: a retrospective analysis.
J
Neurooncol. 2023 Oct 7∟.
doi: 10.1007/s11060-023-04468-3∟.
PMID: 37803102∟.
Observational study˰ ˍ
Liu Y, Lin HT, Zeng W.
Extensive
intraventricular glioblastoma mimicking intracranial
lymphoma.
Neurol
Sci. 2023 Oct 7∟.
doi: 10.1007/s10072-023-07111-1∟.
PMID: 37804369∟.
Case report˰ ˍ
Tam OCH, Ho RSL, Chan S, Li KKW,
Lam TL, Cheung ETY, Cheung OY, Ho WWS, Cheng KKF, Shing MMK, Ku
DTL, Chung BHY, Yang W, Chan GCF, Ng HK, Liu APY.
Genome-Wide
DNA Methylation Profiling as Frontline Diagnostics for Central
Nervous System Embryonal Tumors in Hong Kong.
Cancers
(Basel). 2023 Oct 7;15(19):4880∟.
doi: 10.3390/cancers15194880∟.
PMID: 37835574∟.
Observational study. ˍ
Zhou X, Chen B, Tong P, Li L.
A
case of primary glioma in the cerebellopontine angle region.
Asian
J Surg. 2023 Oct 7:S1015-9584(23)01474-4∟.
doi: 10.1016/j.asjsur.2023.09.059∟.
PMID: 37813794∟.
Letter,
Case report. ˍ
Harness JE, Reis J, Ismail H,
Rossing J, Bylsma FW.
A
- 170 Neuropsychological Findings after Treatment for Recurrent
Left Fronto-Temporal Gemistocytic Astrocytoma.
Arch
Clin Neuropsychol. 2023 Oct 8:acad067.187∟.
doi: 10.1093/arclin/acad067.187∟.
PMID: 37807348∟.
Case report˰ ˍ
Strebler P, Schmitt A.
A
- 114 Long Term Cognitive Sequela of Intracranial Radiation
Therapy in a Pediatric Cerebellar Medulloblastoma Survivor.
Arch
Clin Neuropsychol. 2023 Oct 8:acad067.131∟.
doi: 10.1093/arclin/acad067.131∟.
PMID: 37807253∟.
Case report˰ ˍ
Sun R, Zisakis A, Metcalfe S,
Furtado N.
Intra-cranial
hypertension and vision-threatening papilloedema caused by
intradural spinal tumours: a case series of three.
Br
J Neurosurg. 2023 Oct 8:1-6∟.
doi: 10.1080/02688697.2023.2263087∟.
PMID: 37807636∟.
Case report˰ ˍ
Aboubakr O, Métais A, Hasty
L, Saffroy R, Zanello M, Pallud J, Dhermain F, Varlet P,
Tauziède-Espariat A.
Brainstem
oligodendroglioma, IDH-mutant, and 1P/19Q-codeleted: A potential
diagnostic pitfall.
J
Neuropathol Exp Neurol. 2023 Oct 9:nlad070∟.
doi: 10.1093/jnen/nlad070∟.
PMID: 37812786∟.
Letter, Case report. ˍ
*
Dupere JM, Lucido JJ, Breen WG,
Mahajan A, Stafford SL, Bradley TB, Blackwell CR, Remmes
NB.
Pencil
beam scanning proton therapy for pregnant patients with brain and
head and neck cancers.
Int
J Radiat Oncol Biol Phys. 2023 Oct 9:S0360-3016(23)07953-1∟.
doi: 10.1016/j.ijrobp.2023.09.040∟.
PMID: 37820769∟.
Observational study. ˍ
Inan MA, Ogut B, Toker M, Aricasoy
ON, Vural O, Kuzucu P, Poyraz A.
Retrospective
Analysis of Paediatric Glial Tumours that Required Modern
Molecular Techniques.
Turk
Neurosurg. 2023 Oct 10∟.
doi: 10.5137/1019-5149.JTN.44205-23.1∟.
PMID: 37846542∟.
Observational study. ˍ
Krauze AV, Zhao Y, Li MC, Shih J,
Jiang W, Tasci E, Cooley Zgela T, Sproull M, Mackey M, Shankavaram
U, Tofilon P, Camphausen K.
Revisiting
Concurrent Radiation Therapy, Temozolomide, and the Histone
Deacetylase Inhibitor Valproic Acid for Patients with
Glioblastoma-Proteomic Alteration and Comparison Analysis with the
Standard-of-Care Chemoirradiation.
Biomolecules.
2023 Oct 10;13(10):1499∟.
doi: 10.3390/biom13101499∟.
PMID: 37892181∟.
Observational study. ˍ
Kumagai M, Takata S, Watanabe T,
Shioya A, Han J, Shimasaki M, Ueda Y, Hayashi Y, Yamada
S.
Glioblastoma/high-grade
glioma with a primitive neuronal component including rhabdoid
differentiation that was difficult to diagnose: A case
report.
Pathol
Res Pract. 2023 Oct 10;251:154830∟.
doi: 10.1016/j.prp.2023.154830∟.
PMID: 37890269∟.
Case report˰ ˍ
Rosenberg JG, Nissen K, Heegaard S,
Ragunathan S, Schmiegelow K, Mathiasen R, von Holstein
SL.
Nystagmus
in children with primary brain tumours in Denmark between 2007 and
2017.
Eye
(Lond). 2023 Oct 10∟.
doi: 10.1038/s41433-023-02771-x∟.
PMID: 37816936∟.
Observational study. ˍ
Batchelor TT, Won M, Chakravarti A,
Hadjipanayis CG, Shi W, Ashby LS, Stieber VW, Robins HI, Gray HJ,
Voloschin A, Fiveash JB, Robinson CG, Chamarthy U, Kwok Y, Cescon
TP, Sharma AK, Chaudhary R, Polley MY, Mehta MP.
NRG/RTOG
0837: Randomized, phase II, double-blind, placebo-controlled trial
of chemoradiation with or without cediranib in newly diagnosed
glioblastoma.
Neurooncol
Adv. 2023 Oct 11;5(1):vdad116∟.
doi: 10.1093/noajnl/vdad116∟.
PMID: 38024244∟.
Interventional study. ˍ
Eckhardt A, Drexler R, Schoof M,
Struve N, Capper D, Jelgersma C, Onken J, Harter PN, Weber KJ,
Divé I, Rothkamm K, Hoffer K, Klumpp L, Ganser K, Petersen
C, Ricklefs F, Kriegs M, Schüller U.
Mean
global DNA methylation serves as independent prognostic marker in
IDH wild type glioblastoma.
Neuro
Oncol. 2023 Oct 11:noad197∟.
doi: 10.1093/neuonc/noad197∟.
PMID: 37818983∟.
Observational study˰ ˍ
Krauss P, Kahl KH, Bonk MN, Wolfert
C, Sommer B, Stueben G, Shiban E.
Intraoperative
radiotherapy after resection of brain metastases located in the
posterior fossa. Analysis of postoperative morbidity and mortality
in a single center cohort.
J
Clin Neurosci. 2023 Oct 11;118:1-6∟.
doi: 10.1016/j.jocn.2023.09.014. PMID: 37832264∟.
Observational study˰ ˍ
Lo Greco MC, Milazzotto R, Liardo
RLE, Foti PV, Palmucci S, Basile A, Pergolizzi S, Spatola C.
The
Role of Reirradiation in Childhood Progressive Diffuse Intrinsic
Pontine Glioma (DIPG): An Ongoing Challenge beyond
Radiobiology.
Brain
Sci. 2023 Oct 11;13(10):1449∟.
doi: 10.3390/brainsci13101449∟.
PMID: 37891817∟.
Observational study. ˍ
Mehkri Y, Sharaf R, Reddy A,
Lucke-Wold B.
Letter:
Laser Interstitial Thermal Therapy for First-Line Treatment of
Surgically Accessible Recurrent Glioblastoma: Outcomes Compared
With a Surgical Cohort.
Neurosurgery.
2023 Oct 11∟.
doi: 10.1227/neu.0000000000002721∟.
PMID: 37819105∟.
Comment. ˍ
Refers
to: Fadel
HA, et al., Laser
Interstitial Thermal Therapy for First-Line Treatment of
Surgically Accessible Recurrent Glioblastoma: Outcomes Compared
With a Surgical Cohort. Neurosurgery. 2022 Aug 19∟.
doi: 10.1227/neu.0000000000002093∟.
PMID: 35986677∟.
Observational
study˰ ˍ
-Fadel
HA, Pawloski JA, Lee IY.
In
Reply: Laser Interstitial Thermal Therapy for First-Line Treatment
of Surgically Accessible Recurrent Glioblastoma: Outcomes Compared
With a Surgical Cohort.
Neurosurgery.
2023 Oct 11∟.
doi: 10.1227/neu.0000000000002722∟.
PMID: 37819071∟.
Comment. ˍ
Wang W, Zhao Y, Teng L, Yan J, Guo
Y, Qiu Y, Ji Y, Yu B, Pei D, Duan W, Wang M, Wang L, Duan J, Sun
Q, Wang S, Duan H, Sun C, Guo Y, Luo L, Guo Z, Guan F, Wang Z,
Xing A, Liu Z, Zhang H, Cui L, Zhang L, Jiang G, Yan D, Liu X,
Zheng H, Liang D, Li W, Li ZC, Zhang Z.
Neuropathologist-level
integrated classification of adult-type diffuse gliomas using deep
learning from whole-slide pathological images.
Nat
Commun. 2023 Oct 11;14(1):6359∟.
doi: 10.1038/s41467-023-41195-9∟.
PMID: 37821431∟.
Observational study. ˍ
Das A, Fernandez NR, Levine A,
Bianchi V, Stengs LK, Chung J, Negm L, Dimayacyac JR, Chang Y,
Nobre L, Ercan AB, Sanchez-Ramirez S, Sudhaman S, Edwards M,
Larouche V, Samuel D, Van Damme A, Gass D, Ziegler DS, Bielack SS,
Koschmann C, Zelcer S, Yalon-Oren M, Campino GA, Sarosiek T,
Nichols KE, Loret De Mola R, Bielamowicz K, Sabel M, Frojd CA,
Wood MD, Glover JM, Lee YY, Vanan M, Adamski JK, Perreault S,
Chamdine O, Hjort MA, Zapotocky M, Carceller F, Wright E,
Fedorakova I, Lossos A, Tanaka R, Osborn M, Blumenthal DT, Aronson
M, Bartels U, Huang A, Ramaswamy V, Malkin D, Shlien A, Villani A,
Dirks PB, Pugh TJ, Getz G, Maruvka YE, Tsang DS, Ertl-Wagner B,
Hawkins C, Bouffet E, Morgenstern DA, Tabori U.
Combined
immunotherapy improves outcome for replication repair deficient
(RRD) high-grade glioma failing anti-PD1 monotherapy: A report
from the International RRD Consortium.
Cancer
Discov. 2023 Oct 12∟.
doi: 10.1158/2159-8290.CD-23-0559∟.
PMID: 37823831∟.
Observational study˰ ˍ
Gottardo NG, Gajjar
A.
Verschlimmbesserung:
Craniospinal Radiotherapy is Essential in WNT Medulloblastoma
Patients.
Clin
Cancer Res. 2023 Oct 12∟.
doi: 10.1158/1078-0432.CCR-23-2331∟.
PMID: 37823794∟.
Comment.
ˍ
-Refers
to: Cohen KJ, et al., A
pilot study omitting radiation in the treatment of children with
newly diagnosed Wnt-activated medulloblastoma.
Clin
Cancer Res. 2023 Jul 27:CCR-23-0348∟.
doi: 10.1158/1078-0432.CCR-23-0348∟.
PMID: 37498309∟.
Interventional study˰ ˍ
Schmitz-Abecassis B, Dirven L,
Jiang J, Keller JA, Croese RJI, van Dorth D, Ghaznawi R, Kant IMJ,
Taphoorn MJB, van Osch MJP, Koekkoek JAF, de Bresser J.
MRI
phenotypes of glioblastomas early after treatment are suggestive
of overall patient survival.
Neurooncol
Adv. 2023 Oct 12;5(1):vdad133∟.
doi: 10.1093/noajnl/vdad133∟.
PMID: 37908765∟.
Observational study. ˍ
Hersh AM, Pennington Z, Lubelski D, Elsamadicy AA, Dea N, Desai A,
Gokaslan ZL, Goodwin CR, Hsu W, Jallo GI, Krishnaney A, Laufer I,
Lo SL, Macki M, Mehta AI, Ozturk A, Shin JH, Soliman H, Sciubba
DM.
Treatment of intramedullary spinal
cord tumors: a modified Delphi technique of the North American
Spine Society Section of Spine Oncology.
J Neurosurg
Spine. 2023 Oct 13:1-10∟.
doi: 10.3171/2023.8.SPINE23190∟.
PMID: 37856379∟.
Observational study˰ ˍ
Picart T, Pallud J, Berthiller J,
Dumot C, Berhouma M, Ducray F, Armoiry X, Margier J, Guerre P,
Varlet P, Meyronet D, Metellus P, Guyotat J; Members of RESECT
study group.
Use
of 5-ALA fluorescence-guided surgery versus white-light
conventional microsurgery for the resection of newly diagnosed
glioblastomas (RESECT study): a French multicenter randomized
phase III study.
J
Neurosurg. 2023 Oct 13:1-14∟.
doi: 10.3171/2023.7.JNS231170∟.
PMID: 37856381∟.
Interventional study˰ ˍ
Ramos-Fresnedo A, Al-Kharboosh R, Twohy EL, Basil AN, Szymkiewicz
EC, Zubair AC, Trifiletti DM, Durand N, Dickson DW, Middlebrooks
EH, Abarbanel DN, Tzeng SY, Almeida JP, Chaichana KL, Green JJ,
Sherman WJ, Quiñones-Hinojosa A.
Phase
1, Dose Escalation, Nonrandomized, Open-Label, Clinical Trial
Evaluating the Safety and Preliminary Efficacy of Allogenic
Adipose-Derived Mesenchymal Stem Cells for Recurrent Glioblastoma:
A Clinical Trial Protocol.
Neurosurg
Pract. 2023 Oct 13;4(4):e00062. PMCID:
PMC10923529. PMID:
38464470. Interventional study protocol. ˍ
Sharma P, Medhi PP, Bhattacharyya
M, Nath J, Kalita AK.
Prognostic
Significance of Neutrophil-Lymphocyte Ratio in Patients of
High-Grade Glioma Undergoing Adjuvant Chemoradiation: A
Prospective Study.
Asian
Pac J Cancer Prev. 2023 Oct 13;24(10):3487-3494∟.
doi: 10.31557/APJCP.2023.24.10.3487∟.
PMID: 37898854∟.
Observational study. ˍ
Xiao S, Jiang F, Chen Y, Gong
X.
Development
and validation of a prediction tool for intraoperative blood
transfusion in brain tumor resection surgery: a retrospective
analysis.
Sci
Rep. 2023 Oct 13;13(1):17428∟.
doi: 10.1038/s41598-023-44549-x∟.
PMID: 37833334∟.
Observational study. ˍ
Chiba K, Aihara Y, Oda Y, Masui K, Komori T, Yokoo H, Kawamata
T.
Systemic Metastasis of Pediatric
Diffuse High-grade Astrocytoma: A Case Report.
NMC
Case Rep J. 2023 Oct 14;10:265-271∟.
doi: 10.2176/jns-nmc.2023-0018∟.
PMID: 37953909∟.
Case report. ˍ
*
van den Elshout R, Herings SDA,
Mannil M, Gijtenbeek AMM, Ter Laan M, Smeenk RJ, Meijer FJA,
Scheenen TWJ, Henssen DJHA.
Apparent
Diffusion Coefficient Metrics to Differentiate between
Treatment-Related Abnormalities and Tumor Progression in
Post-Treatment Glioblastoma Patients: A Retrospective
Study.
Cancers
(Basel). 2023 Oct 14;15(20):4990∟. doi:
10.3390/cancers15204990∟.
PMID: 37894355∟.
Observational study. ˍ
Peters KB, Alford C, Heltemes A, Savelli A, Landi DB, Broadwater
G, Desjardins A, Johnson MO, Low JT, Khasraw M, Ashley DM,
Friedman HS, Patel MP.
Use, access, and
initial outcomes of off-label ivosidenib in patients with IDH1
mutant glioma.
Neurooncol
Pract. 2023 Oct 14;11(2):199-204. doi:
10.1093/nop/npad068. PMID:
38496920. Observational study˰
ˍ